The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke
Open accessAbstract
Acute ischemic stroke triggers complex neurovascular, neuroinflammatory and synaptic alterations. Aspirin and docosahexaenoic acid (DHA), an omega-3 essential fatty acid family member, have beneficial effects on cerebrovascular diseases. DHA is the precursor of neuroprotectin D1 (NPD1), which downregulates apoptosis and, in turn, promotes cell survival. Here we have tested the effect of aspirin plus DHA administration and discovered the synthesis of aspirin-triggered NPD1 (AT-NPD1) in the brain. Then we performed the total chemical synthesis of this molecule and tested in the setting of 2h middle cerebral artery occlusion (MCAo) in Sprague-Dawley rats. Neurological status was evaluated at 24h, 48 h, 72 h, and 7 days. At 3h post-stroke onset, an intravenous administration of 333 μg/kg of AT-NPD1 sodium salt (AT-NPD1-SS) or methyl-ester (AT-NPD1-ME) or vehicle (saline) as treatment was given. On day 7, ex vivo magnetic resonance imaging (MRI) of the brains was conducted on 11.7 T MRI. T2WI, 3D volumes, and apparent diffusion coefficient (ADC) maps were generated. In addition, infarct volumes and number of GFAP (reactive astrocytes), ED-1 (activated microglia/macrophages) and SMI-71-positive vessels were counted in the cortex and striatum at the level of the central lesion. All animals showed similar values for rectal and cranial temperatures, arterial blood gases, and plasma glucose during and after MCAo. Treatment with both AT-NPD1-SS and AT-NPD1-ME significantly improved neurological scores compared to saline treatment at 24h, 48 h, 72 h and 7 days. Total lesion volumes computed from T2WI images were significantly reduced by both AT-NPD1-SS and AT-NPD1-ME treatment in the cortex (by 44% and 81%), striatum (by 61% and 77%) and total infarct (by 48% and 78%, respectively). Brain edema, computed from T2WI in the cortex (penumbra) and striatum (core), was elevated in the saline group. In contrast, both AT-NPD1 decreased water content in the striatum on day 7. 3D volumes, computed from T2WI, were dramatically reduced with both AT-NPD1 and the lesion was mostly localized in the subcortical areas. Treatment with both AT-NPD1-SS and AT-NPD1-ME significantly reduced cortical (by 76% and 96%), subcortical (by 61% and 70%) and total (69% and 84%, respectively) infarct volumes as defined by histopathology. In conclusion, a novel biosynthetic pathway that leads to the formation of AT-NPD1 mediator in the brain was discovered. In addition, administration of synthetic AT-NPD1, in either its sodium salt or as the methyl ester, was able to attenuate cerebral ischemic injury which leads to a novel approach for pharmaceutical intervention and clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NPD1 is highlighted here as a neuroprotective mediator in ischemic stroke, as defined by cellular and molecular targets, and demonstrated that the pathway that leads to its formation was enhanced in its neuroprotective bioactivity by the presence of aspirin (Marcheselli et al., 2003) by aspirin-triggered NPD1 (Bazan et al., 2012; Serhan et al., 2015; Serhan and Petasis, 2011).”
From Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection (2018) · cites this paper as Bazan et al., 2012
Experimental — accuracy not yet measuredIn the citing paper
“NPD1 is highlighted here as a neuroprotective mediator in ischemic stroke, as defined by cellular and molecular targets, and demonstrated that the pathway that leads to its formation was enhanced in its neuroprotective bioactivity by the presence of aspirin (Marcheselli et al., 2003) by aspirin-triggered NPD1 (Bazan et al., 2012; Serhan et al., 2015; Serhan and Petasis, 2011).”
From Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection (2018) · cites this paper as Bazan et al., 2012
In the citing paper
“DHA and NPD1 display potent neuroprotective bioactivity when given 1 hour after 2 hours of MCAo in rats (Bazan et al., 2012; Belayev et al., 2018, 2017, 2011; Calandria et al., 2015; Eady et al., 2012; Hong et al., 2015, 2014; Serhan et al., 2011).”
From Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection (2018) · cites this paper as Bazan et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diffusion tensor imaging: Concepts and applications
Le Bihan, D., Mangin, J., Poupon, C., Clark, C. A., Pappata, S., Molko, N., & Chabriat, H. (2001) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1076 · Cited by 3,547
The immunology of stroke: from mechanisms to translation
Iadecola, C., & Anrather, J. (2011) · Nature Medicine · doi:10.1038/nm.2399 · Cited by 2,596
Donnan, G. A., Fisher, M., Macleod, M. R., & Davis, S. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60694-7 · Cited by 2,288
The Science of Stroke: Mechanisms in Search of Treatments
Moskowitz, M. A., Lo, E. H., & Iadecola, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.002 · Cited by 1,930
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Resolvin E1 and protectin D1 activate inflammation-resolution programmes
Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007) · Nature · doi:10.1038/nature05877 · Cited by 1,219
Middle Cerebral Artery Occlusion in the Rat by Intraluminal Suture
Belayev, L., Alonso, O. F., Busto, R., Zhao, W., & Ginsberg, M. D. (1996) · Stroke · doi:10.1161/01.str.27.9.1616 · Cited by 815
Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802
Self-citationMukherjee, P. K., Marcheselli, V. L., Serhan, C. N., & Bazan, N. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402531101 · Cited by 753 · cited 1×
“Given its potent protective actions in the retina and brain, we initially termed this DHA-derived mediator neuroprotectin D1 (NPD1) (Bazan et al., 2010; Mukherjee et al., 2004; Stark and Bazan, 2011a).”
Clària, J., & Serhan, C. N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9475 · Cited by 703
Cited by
Sorted by citations
Pro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041
Self-citationPolyunsaturated fatty acids and their metabolites in brain function and disease
Bazinet, R. P., & Layé, S. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3820 · Cited by 1,703
Dyall, S. C., Balas, L., Bazan, N. G., Brenna, J. T., Chiang, N., Souza, F. D. C., Dalli, J., Durand, T., Galano, J., Lein, P. J., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101165 · Cited by 707
Mammalian lipoxygenases and their biological relevance
Kühn, H., Banthiya, S., & van Leyen, K. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.002 · Cited by 644
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution
Serhan, C. N., Chiang, N., & Dalli, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.004 · Cited by 583
Serhan, C. N. (2017) · The FASEB Journal · doi:10.1096/fj.201601222r · Cited by 566
Serhan, C. N., Dalli, J., Colas, R. A., Winkler, J. W., & Chiang, N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.006 · Cited by 492
Specialized pro-resolving mediator network: an update on production and actions
Chiang, N., & Serhan, C. N. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200018 · Cited by 455
Layé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420
Natural resolution of inflammation
Freire, M., & Dyke, T. E. V. (2013) · Periodontology 2000 · doi:10.1111/prd.12034 · Cited by 414
Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases
Sun, G. Y., Simonyi, Á., Fritsche, K. L., Chuang, D. Y., Hannink, M., Gu, Z., Greenlief, C. M., Yao, J. K., Lee, J. C., & Beversdorf, D. Q. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.03.006 · Cited by 324
Brain docosahexaenoic acid uptake and metabolism
Lacombe, R. J. S., Chouinard‐Watkins, R., & Bazinet, R. P. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.12.004 · Cited by 225
Docosahexaenoic acid (DHA), a fundamental fatty acid for the brain: New dietary sources
Echeverría, F., Valenzuela, R., Hernández‐Rodas, M. C., & Valenzuela, A. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.08.001 · Cited by 220
Devassy, J. G., Leng, S., Gabbs, M., Monirujjaman, M., & Aukema, H. M. (2016) · Advances in Nutrition · doi:10.3945/an.116.012187 · Cited by 192
Giacobbe, J., Benoiton, B., Zunszain, P., Pariante, C. M., & Borsini, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00122 · Cited by 159
Bazan, N. G. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.09.003 · Cited by 148
N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation
Joffre, C., Rey, C., & Layé, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01022 · Cited by 158
Vascular Aspects of Cognitive Impairment and Dementia
Wiesmann, M., Kiliaan, A. J., & Claassen, J. A. H. R. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.159 · Cited by 154
Harrison, J. L., Rowe, R. K., Ellis, T. W., Yee, N., O’Hara, B. F., Adelson, P. D., & Lifshitz, J. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.01.001 · Cited by 124
n-3 Polyunsaturated fatty acids in animal models with neuroinflammation
Orr, S. K., Trépanier, M., & Bazinet, R. P. (2012) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.05.008 · Cited by 115
N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update
Trépanier, M., Hopperton, K. E., Orr, S. K., & Bazinet, R. P. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.045 · Cited by 114
Belayev, L., Hong, S.-H., Menghani, H., Marcell, S. J., Obenaus, A., Freitas, R. S., Khoutorova, L., Balaszczuk, V., Jun, B., Oriá, R. B., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1136-3 · Cited by 103
Self-citationResolution of neuroinflammation: mechanisms and potential therapeutic option
Dokalis, N., & Prinz, M. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00764-1 · Cited by 91
Hong, S., & Lü, Y. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00013 · Cited by 88
Jadhav, A., Tiwari, S., Lee, P. C., & Ndisang, J. F. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.200808 · Cited by 84
Cortina, M. S., He, J., Russ, T. C., Bazan, N. G., & Bazán, H. E. P. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12075 · Cited by 71
n-3 Polyunsaturated Fatty Acids and Their Derivates Reduce Neuroinflammation during Aging
Joffre, C., Dinel, A., Chataigner, M., Pallet, V., & Layé, S. (2020) · Nutrients · doi:10.3390/nu12030647 · Cited by 80
Balas, L., Guichardant, M., Durand, T., & Lagarde, M. (2013) · Biochimie · doi:10.1016/j.biochi.2013.11.006 · Cited by 74
Taha, A. Y., Hennebelle, M., Yang, J., Zamora, D., Rapoport, S. I., Hammock, B. D., & Ramsden, C. E. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.05.004 · Cited by 69
Can inflammation be resolved in Alzheimer’s disease?
Zhu, M., Wang, X., Sun, L., Schultzberg, M., & Hjorth, E. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418791107 · Cited by 62
Central Role of Maladapted Astrocytic Plasticity in Ischemic Brain Edema Formation
Wang, Y., & Parpura, V. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00129 · Cited by 62
McCrary, M. R., Jiang, M., Giddens, M. M., Zhang, J., Owino, S., Wei, Z. Z., Zhong, W., Gu, X.-H., Xin, H., Hall, R., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900070r · Cited by 54
High-mobility group box1 protein promotes neuroinflammation after intracerebral hemorrhage in rats
Lei, C., Lin, S., Zhang, C., Wu, T., Dong, W., Hao, Z., Liu, M., & Wu, B. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.023 · Cited by 59
Bhattacharjee, S., Jun, B., Belayev, L., Heap, J., Kautzmann, M.-A., Obenaus, A., Menghani, H., Marcell, S. J., Khoutorova, L., Yang, R., et al. (2017) · Science Advances · doi:10.1126/sciadv.1700735 · Cited by 57
Vauzour, D., Martinsen, A., & Layé, S. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.08.004 · Cited by 60
Ahluwalia, K., Ebright, B., Chow, K. V., Dave, P., Mead, A., Poblete, R. A., Louie, S. G., & Asante, I. (2022) · Metabolites · doi:10.3390/metabo12040333 · Cited by 56
Direct and indirect effects of lipids on microglia function
Leyrolle, Q., Layé, S., & Nadjar, A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134348 · Cited by 50
Valente, M., Dentoni, M., Bellizzi, F., Kuris, F., & Gigli, G. L. (2022) · Molecules · doi:10.3390/molecules27154836 · Cited by 52
Lipoxygenase: An Emerging Target for Stroke Therapy
van Leyen, K. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273112119990053 · Cited by 51
Bazán, H. A., Lu, Y., Jun, B., Fang, Z., Woods, T. C., & Hong, S. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.08.007 · Cited by 50
Role of metabolic programming in the modulation of microglia phagocytosis by lipids
Nadjar, A. (2018) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.07.006 · Cited by 49
Pro-resolving lipid mediators and therapeutic innovations in resolution of inflammation
Peh, H. Y., & Chen, J. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108753 · Cited by 52
Dihydroxylated E,E,Z-docosatrienes. An overview of their synthesis and biological significance
Balas, L., & Durand, T. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.10.002 · Cited by 47
Hennebelle, M., Metherel, A. H., Kitson, A. P., Otoki, Y., Yang, J., Lee, K. S. S., Hammock, B. D., Bazinet, R. P., & Taha, A. Y. (2018) · Journal of Lipid Research · doi:10.1194/jlr.d084228 · Cited by 42
Dayaker, G., Durand, T., & Balas, L. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201304526 · Cited by 38
Hopperton, K. E., Trépanier, M., James, N. C. E., Chouinard‐Watkins, R., & Bazinet, R. P. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.002 · Cited by 38
Miao, Z., Schultzberg, M., Wang, X., & Zhao, Y. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2020.12.037 · Cited by 34
Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury
Yin, P., Wei, Y., Wang, X., Zhu, M., & Feng, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00617 · Cited by 34
Misfolded Proteins Recognition Strategies of E3 Ubiquitin Ligases and Neurodegenerative Diseases
Chhangani, D., Jana, N. R., & Mishra, A. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8351-0 · Cited by 31
Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine
Cioccari, L., Luethi, N., & Masoodi, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.599853 · Cited by 31
Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases
Shang, P., Zhang, Y., Ma, D., Hao, Y., Wang, X., Xin, M., Zhang, Y., Zhu, M., & Feng, J. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1691525 · Cited by 30
Anatomy and Physiology of the Blood–Brain Barriers
Abbott, N. J. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-9105-7_1 · Cited by 26
Optimization of Nutrition after Brain Injury: Mechanistic and Therapeutic Considerations
Poblete, R. A., Yaceczko, S. D., Aliakbar, R., Saini, P., Hazany, S., Breit, H., Louie, S. G., Lyden, P. D., & Partikian, A. (2023) · Biomedicines · doi:10.3390/biomedicines11092551 · Cited by 31
Polyunsaturated Fatty Acid Metabolism in the Brain and Brain Cells
Joffre, C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88232 · Cited by 30
Trépanier, M., Lim, J., Lai, T. K. Y., Cho, H. J., Domenichiello, A. F., Chen, C. T., Taha, A. Y., Bazinet, R. P., & Burnham, W. M. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.02.020 · Cited by 24
Neurorestorative Targets of Dietary Long-Chain Omega-3 Fatty Acids in Neurological Injury
Figueroa, J. D., & León, M. A. D. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8701-1 · Cited by 25
Neuroprotection after cerebral ischemia
Namura, S., Ooboshi, H., Liu, J., & Yenari, M. A. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12087 · Cited by 23
Formyl peptide receptor 2 as a potential therapeutic target for inflammatory bowel disease
Yang, W., Wang, J., Wu, W., Wang, G., Yan, J., Liu, Q., Wu, X., Zhou, Q., Yang, D., Wang, M., et al. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00944-0 · Cited by 22
The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis
Torres, W., Pérez, J. L., Diaz, M. P., D’Marco, L., Checa-Ros, A., Carrasquero, R., Angarita, L., Gómez, Y., Chacín, M., Ramírez, P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612623 · Cited by 25
Measuring brain docosahexaenoic acid turnover as a marker of metabolic consumption
Klievik, B. J., Tyrrell, A. D., Chen, C. T., & Bazinet, R. P. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108437 · Cited by 24
Zhou, L., Ao, L., Yan, Y., Li, W.-T., Ye, A., Li, C.-Y., Shen, W., Liang, B., Xiong-Zhu, & Li, Y. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.08.053 · Cited by 20
Yasmeen, N., Selvaraj, H., Lakhawat, S. S., Datta, M., Sharma, P. K., Jain, A., Khanna, R., Srinivasan, J., & Kumar, V. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115437 · Cited by 17
Hamazaki, K., & Kim, H. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.01.003 · Cited by 17
GPR37 modulates progenitor cell dynamics in a mouse model of ischemic stroke
Owino, S., Giddens, M. M., Jiang, J. G., Nguyen, T. T., Shiu, F. H., Lala, T., Gearing, M., McCrary, M. R., Gu, X., Wei, L., et al. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113719 · Cited by 16
Bazan, N. G., Reid, M. M., Flores, V. A. C., Gallo, J. E., Lewis, W., & Belayev, L. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09987-x · Cited by 16
Belayev, L., Bazan, N. G., Obenaus, A., Mukherjee, P., Knott, E. J., Khoutorova, L., Reid, M. M., Roque, C. R., Nguyen, L., Lee, J., et al. (2020) · Brain Circulation · doi:10.4103/bc.bc_36_20 · Cited by 15
Rashid, M. A., Haque, M., & Akbar, M. D. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_20 · Cited by 13
Bioactive Lipids in Inflammation After Central Nervous System Injury
López‐Vales, R., & David, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11488-6_12 · Cited by 13
Trépanier, M., Kwong, K.-M., Domenichiello, A. F., Chen, C. T., Bazinet, R. P., & Burnham, W. M. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.05.034 · Cited by 12
COVID-19 and cancer: start the resolution!
Barksdale, C., Kipper, F. C., Tripathy, S., Subbian, S., Serhan, C. N., & Panigrahy, D. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10017-z · Cited by 14
Emerging Roles for the Orphan GPCRs, GPR37 and GPR37 L1, in Stroke Pathophysiology
Mouhi, S., Martin, B., & Owino, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074028 · Cited by 14
Hamidzadeh, K., Westcott, J., Wourms, N., Shay, A. E., Panigrahy, A., Martin, M. J., Nshimiyimana, R., & Serhan, C. N. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115181 · Cited by 12
Ácido docosahexaenoico (DHA), un ácido graso esencial a nivel cerebral
Rodrigo Valenzuela, B., Jessica Morales, P., Julio Sanhueza, C., & Alfonso Valenzuela, B. (2013) · Revista chilena de nutrición · doi:10.4067/s0717-75182013000400009 · Cited by 12
Akhoundzadeh, K., & Shafia, S. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147566 · Cited by 10
The role of bioactive lipids in attenuating the neuroinflammatory cascade in traumatic brain injury
Poblete, R. A., Arenas, M., Sanossian, N., Freeman, W. D., & Louie, S. G. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51240 · Cited by 10
Coppey, L. J., Obrosov, A. A., Shevalye, H., Davidson, E. P., Paradee, W. J., & Yorek, M. A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/5564477 · Cited by 7
Nkiliza, A., Huguenard, C. J. C., Aldrich, G. J., Ferguson, S., Cseresznye, A., Darcey, T. S., Evans, J. E., Dretsch, M. N., MULLAN, M. J., Crawford, F., et al. (2023) · Neurotrauma Reports · doi:10.1089/neur.2023.0045 · Cited by 8
Nieto, Á. A. V., Díaz, A. H., Millán, M. H., & Sagredo, D. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf201 · Cited by 9
Trépanier, M., Hopperton, K. E., Giuliano, V., Masoodi, M., & Bazinet, R. P. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.05.010 · Cited by 6
Common lipidomic signatures across distinct acute brain injuries in patient outcome prediction
Hellström, S., Sajanti, A., Srinath, A., Bennett, C., Girard, R., Jhaveri, A., Cao, Y., Falter, J., Frantzén, J., Koskimäki, F., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106762 · Cited by 6
Aragona, P., Rania, L., Micali, A. G., & Puzzolo, D. (2013) · Current Ophthalmology Reports · doi:10.1007/s40135-013-0011-7 · Cited by 6
Butt, C. M., Harrison, J., Rowe, R. K., Jones, J. R., Wynalda, K., Salem, N., Lifshitz, J., & Pauly, J. (2017) · Current Research Concussion · doi:10.1055/s-0037-1606836 · Cited by 5
Reid, M. M., Obenaus, A., Mukherjee, P. K., Khoutorova, L., Roque, C. R., Petasis, N. A., Oriá, R. B., Belayev, L., & Bazan, N. G. (2022) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2022.106585 · Cited by 6
Novel Lipid Mediators as a Promising Therapeutic Strategy for Ischemic Stroke
Belayev, L., Reid, M. M., & Bazan, N. G. (2023) · Medical Research Archives · doi:10.18103/mra.v11i1.3333 · Cited by 5
Nieto, Á. A. V., Díaz, A. H., & Hernández, M. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00633-4 · Cited by 6
Lipid metabolism, microglia, and stroke
Chen, L., Zhang, M., Wei, W., Li, Q., Wang, L., Zhao, M., He, L., Xu, H., Yang, P., & Zhang, P. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01523 · Cited by 7
Poblete, R. A., Arenas, M., Sanossian, N., Hong, Y., Freeman, W. D., Lyden, P. D., & Louie, S. G. (2022) · PubMed Central · Cited by 5
Anti-Inflammatory, Neurotrophic, and Cytotoxic Oxylipins Isolated from Chaenomeles sinensis Twigs
Lee, D. Y., Park, K.-J., Subedi, L., Lee, G. S., Lee, J., Lee, W.-M., Choi, S. U., Hong, S., Kim, S. Y., & Kim, C. S. (2023) · Antioxidants · doi:10.3390/antiox12020284 · Cited by 5
Hopperton, K. E., James, N. C. E., Mohammad, D., Irfan, M., & Bazinet, R. P. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1396068 · Cited by 5
Lipid Metabolism in Cerebral Ischemia: From Pathogenesis to Therapy
Wang, X., Liu, R., Chen, Z., Hu, W., & Jiang, L. (2025) · Current Neuropharmacology · doi:10.2174/011570159x389784250715064745 · Cited by 4
Scoping review of disease-modifying effect of drugs in experimental epilepsy
Ots, H. D., Anderson, T., Sherrerd-Smith, W., DelBianco, J., Rasic, G., Chuprin, A., Toor, Z., Fitch, E., Ahuja, K. R., Reid, F., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1097473 · Cited by 4
Fish and Fish Oil for the Aging Brain
Butt, C. M., & Salem, N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802844-5.00012-9 · Cited by 5
Anatomy and Physiology of the Blood-Brain Barriers*
Abbott, N. J. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_1 · Cited by 4
Gonçalves, W. A., Melão, A. C. R., Teixeira, M. M., Rezende, B. M., & Pinho, V. (2018) · Springer eBooks · doi:10.1007/978-3-319-77658-3_6 · Cited by 3
Lu, X., Rehman, H., & Markworth, J. F. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_344 · Cited by 2
N-3 PUFAs and neuroinflammatory processes in cognitive disorders
Leyrolle, Q., Layé, S., & Nadjar, A. (2016) · OCL · doi:10.1051/ocl/2015064 · Cited by 4
Mahmoud, S., Latif, Y. A., Orban, H. A., Ibrahim, A., & Hussein, J. (2020) · AFMN Biomedicine · doi:10.5937/afmnai38-28984 · Cited by 2
Sarcopenia and the inflammatory cytokines
Orzechowski, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822146-4.00008-9 · Cited by 2
Cerebro-Cardiovascular Diseases
Land, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53868-2_11 · Cited by 2
n-3 Fatty Acid-Derived Lipid Mediators against Neurological Oxidative Stress and Neuroinflammation
Farooqui, A. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410527-0.00007-7 · Cited by 2
Metadata
- Authors
- Bazan, N. G., Eady, T. N., Khoutorova, L., Atkins, K. D., Hong, S., Lu, Y., Zhang, C., Jun, B., Obenaus, A., Fredman, G., Zhu, M., Winkler, J. W., Petasis, N. A., Serhan, C. N., & Belayev, L.
- Affiliations
- Louisiana State University Health Sciences Center New Orleans (US)
- Brigham and Women's Hospital (US)
- University of Southern California (US)
- Corresponding author
- Bazan, Nicolas G.
- ORCID
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 236
- Issue
- 1
- Pages
- 122-130
- ISSN
- 0014-4886 (ISSN-L)
- PMC
- PMC3409566
- OpenAlex
- W2039267832
- Cited by
- 121
- References
- 34
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 3 · 2023: 8 · 2022: 10 · 2021: 8 · 2020: 8 · 2019: 9 · 2018: 9 · 2017: 10 · 2016: 7 · 2015: 8 · 2014: 13 · 2013: 13 · 2012: 4
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Center for Complementary and Alternative Medicine
- National Institute of Neurological Disorders and Stroke (R01NS046741)
- National Center for Complementary and Integrative Health (RC2AT005909)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- neuroprotectin D1, aspirin, docosahexaenoic acid, acute ischemic stroke, cerebral ischemia, middle cerebral artery occlusion, neuroprotection, infarct size, cerebral edema, neuroinflammation, microglia/macrophages, astrocytes, omega-3 fatty acids, chemical synthesis
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Brain Ischemia, Docosahexaenoic Acids, Male, Rats, Sprague-Dawley, Infarction, Middle Cerebral Artery, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
